A detailed history of Aigh Capital Management LLC transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Aigh Capital Management LLC holds 1,211,509 shares of EGRX stock, worth $629,984. This represents 1.82% of its overall portfolio holdings.

Number of Shares
1,211,509
Previous 1,211,509 -0.0%
Holding current value
$629,984
Previous $6.78 Million 33.76%
% of portfolio
1.82%
Previous 2.46%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$3.34 - $5.6 $83,500 - $140,000
25,000 Added 2.11%
1,211,509 $6.78 Million
Q1 2024

May 14, 2024

BUY
$4.26 - $6.51 $5.05 Million - $7.72 Million
1,186,509 New
1,186,509 $6.22 Million

Others Institutions Holding EGRX

About EAGLE PHARMACEUTICALS, INC.


  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $6.77M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Aigh Capital Management LLC Portfolio

Follow Aigh Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aigh Capital Management LLC with notifications on news.